Valuation : StimCell Energetics Inc.

Market Cap 4.65M 4.01M 3.8M 3.44M 6.45M 444M 6.49M 45.04M 17.33M 226M 17.47M 17.08M 714M P/E 2027 *
-11x
P/E 2028 * -
Enterprise Value 5.45M 4.7M 4.45M 4.03M 7.56M 521M 7.6M 52.79M 20.31M 265M 20.47M 20.02M 837M EV / Sales 2027 *
-
EV / Sales 2028 * 9.09x
Free-Float
28.33%
Yield 2027 *
-
Yield 2028 * -
1 week+8.21%
Current month+37.73%
1 month-12.93%
3 months-13.16%
6 months+0.97%
Current year-24.25%
1 week 0.22
Extreme 0.22
0.3
1 month 0.18
Extreme 0.18
0.3
Current year 0.18
Extreme 0.18
0.48
1 year 0.18
Extreme 0.18
0.48
3 years 0
Extreme 0.0015
3.42
5 years 0
Extreme 1.4E-5
13.97
10 years 0
Extreme 1.4E-5
25.35
Manager TitleAgeSince
Chief Executive Officer 56 12/12/2023
Director of Finance/CFO 48 24/11/2014
Director TitleAgeSince
Chairman 74 26/02/2024
Director/Board Member 62 08/06/2020
Director/Board Member 56 12/12/2023
Date Insider Type Main position Quantity % Market Cap. Importance
18/12/25 Sell

Director

16,667 0.0807%
17/3/25 Tax

Director

60,841,472 -
25/2/25 Buy 15,000 0.0757%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+8.21%+12.22%-45.41% 4.65M
-0.71%-8.73%-4.56%+9.80% 46.05B
+0.21%-3.37%+403.76%+534.40% 43.59B
+1.74%-3.63%+42.37%+22.59% 42.35B
+1.38%-4.46%+10.38%+79.88% 38.86B
-1.44%-4.76%+10.26%+38.52% 32.24B
+0.87%-2.81% - - 17.16B
+0.75%-0.99%+23.25%+116.71% 16.28B
-0.31%-3.76%+12.33%+30.49% 14.32B
+1.93%-5.14%+81.55%+39.31% 13.03B
Average +0.32%-4.28%+65.73%+91.81% 26.39B
Weighted average by Cap. +0.20%-5.10%+87.28%+129.27%

Financials

2027 *2028 *
Net sales - 600K 517K 490K 444K 832K 57.32M 837K 5.81M 2.24M 29.13M 2.25M 2.2M 92.13M
Net income -510K -440K -416K -377K -707K -48.73M -711K -4.94M -1.9M -24.76M -1.92M -1.87M -78.31M -
Net Debt 800K 690K 653K 592K 1.11M 76.43M 1.12M 7.75M 2.98M 38.84M 3M 2.94M 123M 800K 690K 653K 592K 1.11M 76.43M 1.12M 7.75M 2.98M 38.84M 3M 2.94M 123M
Logo StimCell Energetics Inc.
StimCell Energetics Inc. is a biotech company, which is focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications including, but not limited to aging, insulin sensitivity, high blood pressure, neuropathy and kidney function. The Company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System. eBalance is a non-invasive, fully automated microcurrent electrotherapy system administering pre-programmed algorithms through the epidermis at the touch of a button to help you gain optimal wellness and reduce pain. Its eBalance represents a monumental stride in the realm of medical technology designed to rejuvenate and re-energize the human body at a cellular level. The operation of eBalance is an intricate process of precision engineering and human biology.
Employees
1
Date Price Change Volume

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STME Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!